Literature DB >> 17513516

Falsely normal C4 in a case of acquired C1 esterase inhibitor deficiency.

Andrew McLean-Tooke1, Catherine Stroud, Anne Sampson, Gavin Spickett.   

Abstract

A 59-year-old lady presented with recurrent angioedema without urticaria. The clinical history and examination were consistent with an acquired C1 esterase deficiency secondary to lymphoproliferative disease. Despite a low C1 esterase level, the C4 level assayed by nephelometry on our automated analyser was normal. Analysis using different nephelometric analysers revealed consistently low C4, despite consistent normal readings in our analyser. Further investigation revealed an IgM-kappa paraprotein that seemed to interfere with both this and haematology coagulation assays. Splenic marginal zone lymphoma was confirmed on bone marrow biopsy. Monoclonal paraproteins may interfere with nephelometric, turbidimetric and immunological assays in a non-antibody-specific manner and should be considered when there are unusual or unexpected results, particularly in a patient with lymphoproliferative disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513516      PMCID: PMC1994549          DOI: 10.1136/jcp.2006.041350

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

Review 1.  Acquired C1 esterase inhibitor deficiency.

Authors:  S N Markovic; D J Inwards; E A Frigas; R P Phyliky
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

2.  False-positive reactions for IgA anti-phospholipid and anti-beta(2)-glycoprotein I antibodies in patients with IgA monoclonal gammopathy.

Authors:  N Bizzaro; P Pasini; B Finco
Journal:  Clin Chem       Date:  1999-11       Impact factor: 8.327

3.  A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency.

Authors:  M M Gompels; R J Lock; J E Morgan; J Osborne; A Brown; P F Virgo
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

4.  Paraprotein interference in automated chemistry analyzers.

Authors:  Chelsea A Sheppard; Robert C Allen; Garth E Austin; Andrew N Young; Maria A Ribeiro; Corinne R Fantz
Journal:  Clin Chem       Date:  2005-06       Impact factor: 8.327

5.  Multiple autoimmune phenomena in splenic marginal zone lymphoma.

Authors:  Panayiotis D Ziakas; Stavroula Giannouli; Anna Tasidou; Fotini N Skopouli; Michael Voulgarelis
Journal:  Leuk Lymphoma       Date:  2006-04

6.  False increase in serum C-reactive protein caused by monoclonal IgM-lambda: a case report.

Authors:  A Yu; U Pira
Journal:  Clin Chem Lab Med       Date:  2001-10       Impact factor: 3.694

7.  Interference with nephelometric assay of C-reactive protein by monoclonal immunoglobulin.

Authors:  M Lammers
Journal:  Clin Chem       Date:  1998-07       Impact factor: 8.327

8.  Interference with nephelometric assay of C-reactive protein and antistreptolysin-O by monoclonal IgM-kappa from a myeloma patient.

Authors:  K Yamada; A Yagihashi; S Ishii; K Tanemura; T Kida; N Watanabe; Y Niitsu
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

9.  False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion.

Authors:  S Cowchock; J Fort; S Munoz; R Norberg; W Maddrey
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

10.  Rheumatic autoantibodies in the sera of patients with paraproteins.

Authors:  K L Hardiman; S Horn; A Manoharan; K Phadke; J Gibson; L McGuigan; A Sturgess
Journal:  Clin Exp Rheumatol       Date:  1994 Jul-Aug       Impact factor: 4.473

View more
  2 in total

Review 1.  Clinical Immunology Review Series: An approach to the patient with angio-oedema.

Authors:  S Grigoriadou; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

2.  Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse events.

Authors:  Zhao-Hua Zhou; Trina Chen; Kamalpreet Arora; Kenneth Hyams; Steven Kozlowski
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.